Key Takeaways
- Bankable funds H-1B biotech/lab businesses up to $5M based on documented revenue
- No green card, no permanent residency, no citizenship required for funding
- SBA March 2026 rule eliminated H-1B owners from all SBA 7(a) loan access
- 48-hour funding decisions — faster than any bank or SBA lender
- Check your Bankability Score in 30 seconds — no SSN upload
Biotech startups and contract research labs represent the highest-risk, highest-potential sector in H-1B entrepreneurship. H-1B scientists and researchers who founded biotech companies are doing the work that defines American scientific leadership — yet they now face the double challenge of biotech's inherent capital intensity and visa-based exclusion from SBA research and development loans.
H-1B biotech founders typically hold PhDs in biology, chemistry, or biochemistry and have spent years in corporate research roles before launching their own ventures. Contract research organizations (CROs), diagnostic lab businesses, and pre-revenue biotech startups all require laboratory equipment, regulatory compliance infrastructure, and working capital that traditional lenders refuse to provide to non-citizens.
The March 2026 SBA rule eliminated H-1B biotech/lab businesses from all 7(a) access. Bankable provides a direct path to revenue-based funding without any citizenship test.
Capital Uses for H-1B Biotech/Lab Operators
- Laboratory Equipment: Mass spectrometers, PCR machines, cell culture equipment, and analytical instruments. Lab equipment for a research-grade setup: $200,000 to $2M.
- Regulatory and IP Costs: FDA pre-submission meetings, IP filings, and regulatory consultant fees for medical device or drug development programs.
- Clinical Trial Support: Sample collection, patient recruitment, and contract research infrastructure for early-phase clinical studies.
- Facility Buildout: Biosafety cabinet installation, HVAC validation, and clean room construction for GMP-compliant lab spaces.
- Bridge to Grant Funding: Bankable bridges the gap between SBIR/STTR grant award notification and actual disbursement, which can take 3 to 6 months.
| Funding Source | H-1B Eligible? | Max Amount | Speed |
|---|---|---|---|
| SBA 7(a) — March 2026+ | No — US citizens only | $5M | 30–90 days |
| Traditional Banks | Rarely | Varies | 3–6 weeks |
| Bankable | Always yes | $5M | 48 hours |
For the full SBA alternative landscape for H-1B business owners, see our SBA alternative guide. Check your Bankability Score in 30 seconds to see your preliminary funding range.
Frequently Asked Questions
Yes. Bankable funds biotech/lab businesses based on documented revenue. No green card or permanent residency required.
Effective March 1, 2026, the SBA requires 100% US citizen ownership. All H-1B business owners are excluded from SBA 7(a) loans.
Minimum $50,000 in monthly revenue for initial consideration. Businesses at qualifying revenue levels access initial tranches of $200K to $2M.
48-hour decision from completed application. The Bankability Assessment at /bankability-score/ gives a preliminary range in 30 seconds.
No. Bankable funds H-1B holders as sole applicants based on business revenue alone.
No. Bankable has zero residency requirements. H-1B, L-1, O-1, and other work visa holders all qualify for funding assessment based on business revenue alone.
Effective March 1, 2026, the SBA requires 100% US citizen or national ownership for all 7(a) and 504 programs. H-1B holders are completely excluded regardless of revenue or credit history.
48 hours from completed application. The Bankability Assessment at /bankability-score/ takes 30 seconds and gives a preliminary range immediately.